Supply and Demand for Scientists

As new graduates in science and engineering are learning, it is not as easy to get job offers as it was two or three years ago. However, as the number of graduates starts to fall with the drop in the college age population, employment opportunities are expected to expand, and many forecasters project significant shortages of EMPs—engineers, math and computer scientists, and physical scientists— through much of the next decade. The key to correct forecasting, of course, is to be able

Written byBetty Vetter
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

The key to correct forecasting, of course, is to be able to anticipate both the economy, and the decisions of the administration and Congress on allocation of federal funds. Continued emphasis on the President's Strategic Defense Initiative means more demand for physicists, computer specialists, aeronautical engineers and materials scientists. A decision to rebuild the nation's infrastructure would create demand for civil engineers and architects, while more funding for health research and care for an aging population or AIDS patients would increase jobs for biomedical specialists. A flat or falling economy reduces demand for all workers; Unfortunately, we don't anticipate political decisions or economic trends very well.

Although we speak of supply and demand as though they were actual, measurable numbers, this really is not true. Simplistically, we project supply as the number of new graduates expected, plus cur rent workers minus those who die or retire. Actually, supply always includes ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies